Status:
COMPLETED
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Lead Sponsor:
Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Several observational studies have evaluated the comparative treatment costs associated with each agent, particularly those within the anti-TNF class, but few have evaluated the impact of therapy comp...
Detailed Description
Cohort observational
Eligibility Criteria
Inclusion
- Adults with moderate to severe RA who are currently using a DMARD
Exclusion
- Psoriatic Arthritis (PsA), Psoriasis (PsO), SSystemic Lupus Erythematosus (SLE), Non-Disease modifying anti-rheumatic disease (non-DMARD) use
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT01438892
Start Date
February 1 2012
End Date
January 1 2013
Last Update
April 8 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.